Verici Dx plc (LON:VRCI – Get Free Report)’s share price traded down 10.3% during mid-day trading on Friday . The company traded as low as GBX 5.16 ($0.06) and last traded at GBX 5.16 ($0.06). 1,575,868 shares traded hands during trading, an increase of 20% from the average session volume of 1,313,229 shares. The stock had previously closed at GBX 5.75 ($0.07).
Verici Dx Trading Down 10.3 %
The firm’s 50-day moving average price is GBX 3.25 and its 200 day moving average price is GBX 5.27. The company has a market cap of £12.50 million, a price-to-earnings ratio of -257.75 and a beta of 1.59. The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.65.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns
- The Most Important Warren Buffett Stock for Investors: His Own
- Is Domino’s Recent Dip a Recipe for Long-Term Gains?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
